Skip to main content
TipRanks
Go Ultimate75% OFF

Iradimed (46K) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

46K Analyst Ratings

Hold
1Ratings
0Buy1Hold0Sell
Based on 1 analysts giving stock ratings to Iradimed in the past 3 months

46K Stock 12 Month Forecast

There Are No Analyst Ratings for 46K In The Last 3 Months.

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for DE:46K
Price TargetArticle
Needham―hold―Initiated09/22/26
Lake Street€108.14buy40.44%UpsideReiterated08/03/26
Freedom Capital Markets€104.54buy35.76%UpsideInitiated04/02/26
Roth MKM€88.32→€108.14buy40.44%UpsideReiterated02/11/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
DFTXDefinium Therapeutics
RDNTRadnet
AXGNAxoGen
PLSEPulse Biosciences
AHCOAdaptHealth

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Iradimed

3 Months
Frank Takkinen
Frank TakkinenLake Street
Success Rate8/16 ratings generated profit
50%
Average Return
+3.71%

Copying Frank Takkinen's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +3.71% per trade.

1 Year
Frank Takkinen
Frank TakkinenLake Street
Success Rate12/16 ratings generated profit
75%
Average Return
+28.78%

Copying Frank Takkinen's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +28.78% per trade.

2 Years
Frank Takkinen
Frank TakkinenLake Street
Success Rate14/16 ratings generated profit
88%
Average Return
+61.98%

Copying Frank Takkinen's trades and holding each position for 2 Years would result in 87.50% of your transactions generating a profit, with an average return of +61.98% per trade.

46K Analyst Recommendation Trends

01234Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for 46K
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy00000
Buy01110
Hold00111
Sell00000
Strong Sell00000
total01221

In the current month, 46K has received 0 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. 46K average Analyst price target in the past 3 months is ―.

46K Financial Forecast

€-1€-0.5€0€0.5€1Q1 2026Q3 2026Q4 2026
High€0.53
Consensus€0.53
Low€0.52

46K Earnings Forecast

Next quarter’s earnings estimate for 46K is EUR 0.53 with a range of EUR 0.52 to EUR 0.53. The previous quarter’s EPS was EUR 0.49. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

€18.2M€19.5M€20.7M€22M€23.2MQ1 2026Q3 2026Q4 2026
High€23.2M
Consensus€22.6M
Low€22.2M

46K Sales Forecast

Next quarter’s sales forecast for 46K is EUR 22.57M with a range of EUR 22.24M to EUR 23.22M. The previous quarter’s sales results were EUR 21.53M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

46K Stock Forecast FAQ

Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Iradimed a Buy, Sell or Hold?
Iradimed has a consensus rating of Hold, which is based on 0 buy ratings, 1 hold ratings and 0 sell ratings.
What do analysts say about Iradimed?
Iradimed’s analyst rating consensus is a Hold. This is based on the ratings of 1 Wall Street analysts.
How can I buy shares of Iradimed?
To buy shares of DE:46K, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.